Abbott Labs Is a Rare Growth Story in Health Care

The reason to buy shares in Abbott Labs is simple:The company is growing its top line faster than just about any health-care company of comparable size and since it doesn’t sell pharmaceuticals in the U.S., it is relatively insulated from regulatory risk.

from WSJ.com: Markets https://ift.tt/2nTe8gN
via IFTTT

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s